Ordena

Cercar

01/08/2021 Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations
Martin, I, Villamon, E, Abellan, R, Calasanz, MJ, Irigoyen, A, Sanz, G, Such, E, Mora, E, Gutierrez, M, Collado, R, Garcia-Serra, R, Vara, M, Blanco, ML, Oiartzabal, I, Alvarez, S, Bernal, T, Granada, I, Xicoy, B, Jerez, A, Calabuig, M, Diez, R, Gil, A, Diez-Campelo, M, Solano, C, Tormo, M. Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. BRITISH JOURNAL OF HAEMATOLOGY. 2021; 194(4)DOI:10.1111/bjh.17675. PMID:34296432. IF:8.615(Q1/2D).
01/08/2021 Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines
Alamo, P, Cedano, J, Conchillo-Sole, O, Cano-Garrido, O, Alba-Castellon, L, Serna, N, Avino, A, Carrasco-Diaz, LM, Sanchez-Chardi, A, Martinez-Torro, C, Gallardo, A, Cano, M, Eritja, R, Villaverde, A, Mangues, R, Vazquez, E, Unzueta, U. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines. Acta Biomaterialia. 2021; 130DOI:10.1016/j.actbio.2021.06.001. PMID:34116228. IF:10.633(Q1/2D).
01/08/2021 Current Trends and Controversies in the Management of Warthin Tumor of the Parotid Gland
Quer, M, Hernandez-Prera, JC, Silver, CE, Casasayas, M, Simo, R, Vander Poorten, V, Guntinas-Lichius, O, Bradley, PJ, Tong-Ng, W, Rodrigo, JP, Makitie, AA, Rinaldo, A, Kowalski, LP, Sanabria, A, de Bree, R, Takes, RP, Lopez, F, Olsen, KD, Shaha, AR, Ferlito, A. Current Trends and Controversies in the Management of Warthin Tumor of the Parotid Gland. Diagnostics. 2021; 11(8)DOI:10.3390/diagnostics11081467. PMID:34441400. IF:3.992(Q2/4D).
01/08/2021 Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
Kharfan-Dabaja, MA, Kumar, A, Ayala, E, Aljurf, M, Nishihori, T, Marsh, R, Burroughs, LM, Majhail, N, Al-Homsi, AS, Al-Kadhimi, ZS, Bar, M, Bertaina, A, Boelens, JJ, Champlin, R, Chaudhury, S, DeFilipp, Z, Dholaria, B, El-Jawahri, A, Fanning, S, Fraint, E, Gergis, U, Giralt, S, Hamilton, BK, Hashmi, SK, Horn, B, Inamoto, Y, Jacobsohn, DA, Jain, T, Johnston, L, Kanate, AS, Kansagra, A, Kassim, A, Kean, LS, Kitko, CL, Knight-Perry, J, Kurtzberg, J, Liu, H, MacMillan, ML, Mahmoudjafari, Z, Mielcarek, M, Mohty, M, Nagler, A, Nemecek, E, Olson, TS, Oran, B, Perales, MA, Prockop, SE, Pulsipher, MA, Pusic, I, Riches, ML, Rodriguez, C, Romee, R, Rondon, G, Saad, A, Shah, N, Shaw, PJ, Shenoy, S, Sierra, J, Talano, J, Verneris, MR, Veys, P, Wagner, JE, Savani, BN, Hamadani, M, Carpenter, PA. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. Transplantation And Cellular Therapy. 2021; 27(8)DOI:10.1016/j.jtct.2021.04.007. PMID:34304802. IF:(Q/D).
01/08/2021 Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group
Bueno, F, Solano, C, Vazquez, L, Gimenez, E, de la Camara, R, Albert, E, Rovira, M, Espigado, I, Calvo, CM, Lopez-Jimenez, J, Suarez-Lledo, M, Chinea, A, Esquirol, A, Perez, A, Bermudez, A, Saldana, R, Heras, I, Gonzalez-Huerta, AJ, Torrado, T, Batlle, M, Jimenez, S, Vallejo, C, Barba, P, Cuesta, MA, Duarte, R, Pinana, JL, Navarro, D. Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group. Transplant Infectious Disease. 2021; 23(4)DOI:10.1111/tid.13627. PMID:33908148. IF:2.867(Q3/6D).
01/08/2021 Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Bento, L, Gutierrez, A, Novelli, S, Montoro, J, Pinana, JL, Lopez-Corral, L, Cabrero, M, Martin-Sancho, A, Gutierrez-Garcia, G, Ortiz-Moscovich, M, Bastos-Oreiro, M, Dorado, N, Perez, A, Hernani, R, Ferra, C, Parody, R, Garcia-Cadenas, I, Herrera, P, Rodriguez, G, Rodriguez, N, Martin, C, Yanez, L, Zanabili, J, Varela, MR, Lopez-Godino, O, Heras, I, Espanol, I, Martinez, C, Perez-Simon, JA, Solano, C, Sureda, A, Sierra, J, Sampol, A, Caballero, D. Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. BONE MARROW TRANSPLANTATION. 2021; 56(8)DOI:10.1038/s41409-021-01264-3. PMID:33767400. IF:5.174(Q2/3D).